Sorry here is the update link.http://www.theaustralian.news.com.au/business/story/0,28124,25897797-5012439,00.htmlI do not endorse this hyperlink.Position held in Tatts group (TTS).
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling